The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Reasoning
The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Cite this ruling
CBP Ruling N022256 (3004909120): The tariff classification of Bromocriptine Mesylate Tablets (2.5 mg) and Capsules (5 mg), Bicalutamide Tablets (50 mg), and Dipyridamole Tablets (25mg, 50 mg, 75 mg) from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of ISK247, imported in bulk and capsule forms, from Switzerland
The tariff classification of Ramipril in capsule dosage form, from India
The tariff classification of Lansoprazole (CAS-103577-45-3) in dosage (capsule) form, from Slovenia
The tariff classification of Cap Lang’s Red Flower Oil in dosage form, from Indonesia
The tariff classification of F.E. Casca-Plus capsules in dosage form, from New Zealand